Results 41 to 50 of about 282,889 (214)
Since the early 2000s, pneumococcal conjugate vaccines (PCVs) have been shown to be effective in the prevention of pneumonia and invasive pneumococcal diseases.
I. Rivero-Calle +7 more
doaj +1 more source
Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines. [PDF]
Bacterial polysaccharides have numerous clinical or industrial uses. Recombinant plants could offer the possibility of producing bacterial polysaccharides on a large scale and free of contaminating bacterial toxins and antigens.
G. C. Whitelam (7665758) +58 more
core +1 more source
Background: Pneumonia is one of the major causes of morbidity, mortality, and hospitalization. It is developed by a variety of organisms including Streptococcus pneumoniae and Legionella spp.
Tina Rabooki +4 more
doaj +1 more source
Pneumococcic Vaccine In Pneumonia [PDF]
n ...
openaire +1 more source
Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.
BackgroundStreptococcus pneumoniae is a leading cause of pneumonia worldwide. However, the burden of pneumococcal pneumonia among adults in low- and middle-income countries is not well described.MethodsData from 2008-2012 was analyzed from two ...
Carmen Lucía Contreras +9 more
doaj +1 more source
BACKGROUND AND AIM OF THE WORK: Since the introduction of the 7-valent vaccine, invasive pneumococcal disease have greatly decreased; however, changes in the distribution of pneumococcal serotypes have recently highlighted the need for vaccines with ...
Valleriani, Claudia +26 more
core +2 more sources
Continued control of pneumococcal disease in the UK - the impact of vaccination
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mortality in the developed and developing world. Pneumococcal conjugate vaccines were first introduced for routine use in the USA in 2000, although the seven-
Gladstone, R.A. +11 more
core +1 more source
Background Pneumococcal pneumonia causes high morbidity and mortality among adults. This study aimed to identify risk factors for bacteremic pneumococcal pneumonia, and to construct a prediction model for the development of bacteremia in patients with ...
Yasuyoshi Washio +4 more
doaj +1 more source
Vaccination and antimicrobial therapy remain the cornerstones of the management of pneumococcal pneumonia. Despite significant successes, the capacity of the pneumococcus to evolve in the face of the selective pressure of anticapsular immunity challenges immunization programs.
Dockrell, David H. +2 more
openaire +2 more sources
Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
Bottomley, Christian +15 more
core +1 more source

